Literature DB >> 10971526

CD14+CD16+ monocyte subpopulation in Kawasaki disease.

K Katayama1, T Matsubara, M Fujiwara, M Koga, S Furukawa.   

Abstract

Kawasaki disease (KD) is an acute febrile illness caused by vasculitis, occurring in early childhood. We have demonstrated that the activation of monocytes/macrophages plays a central role during acute KD. Recently, it has been reported that the CD14+CD16+ monocyte subpopulation plays a more important role in inflammation. In this study, we investigated the peripheral blood CD14+CD16+ monocyte subpopulation by flow cytometry, and serum levels of IL-10 and IL-12 using a sandwich ELISA in 28 KD patients. We also investigated this subpopulation in patients with bacterial infections, mononucleosis and anaphylactoid purpura, since the cause of KD remains unknown. We observed an increase in the number of CD14+CD16+ monocytes with acute KD, which was a positive correlation with C-reactive protein levels, and we observed only the patients with severe bacterial infections had increased this subpopulation during the acute stage among control diseases. In addition, we found that the serum levels of IL-10, but not IL-12, were higher during acute KD. These data suggest that increased peripheral blood CD14+CD16+ monocytes are part of the regulatory system of monocyte function during acute KD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971526      PMCID: PMC1905728          DOI: 10.1046/j.1365-2249.2000.01321.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Increased expression of CD23 on peripheral blood B cells and macrophages/monocytes during acute infectious mononucleosis.

Authors:  S Furukawa; T Motohashi; T Matsubara; T Watanabe; T Obara; K Yabuta
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

2.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation.

Authors:  H W Ziegler-Heitbrock
Journal:  Immunol Today       Date:  1996-09

3.  High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.

Authors:  J Hirao; S Hibi; T Andoh; T Ichimura
Journal:  Int Arch Allergy Immunol       Date:  1997-02       Impact factor: 2.749

4.  Immunopathology of the skin lesion of Kawasaki disease.

Authors:  T Sugawara; S Hattori; S Hirose; S Furukawa; K Yabuta; T Shirai
Journal:  Prog Clin Biol Res       Date:  1987

Review 5.  Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.

Authors:  J M Anaya; L R Espinoza
Journal:  J Rheumatol       Date:  1995-04       Impact factor: 4.666

6.  Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

Authors:  M Terai; Y Kohno; M Namba; T Umemiya; K Niwa; H Nakajima; A Mikata
Journal:  Hum Pathol       Date:  1990-02       Impact factor: 3.466

7.  Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.

Authors:  F Zeni; P Pain; M Vindimian; J P Gay; P Gery; M Bertrand; Y Page; D Page; R Vermesch; J C Bertrand
Journal:  Crit Care Med       Date:  1996-02       Impact factor: 7.598

8.  Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.

Authors:  S Furukawa; T Matsubara; Y Umezawa; T Motohashi; T Ino; K Yabuta
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

9.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Interleukin-10 drives human monocytes to CD16 positive macrophages.

Authors:  J C Calzada-Wack; M Frankenberger; H W Ziegler-Heitbrock
Journal:  J Inflamm       Date:  1996
View more
  28 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

3.  Selective expansion of CD16highCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation.

Authors:  K Mizuno; T Toma; H Tsukiji; H Okamoto; H Yamazaki; K Ohta; K Ohta; Y Kasahara; S Koizumi; A Yachie
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 4.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  J Neuroimmunol       Date:  2006-06-21       Impact factor: 3.478

6.  Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease.

Authors:  Jianmei Zhang; Wenbin Chen; Li Fang; Qiu Li; Xu Zhang; Haiqing Zhang; Qingbo Guan; Rang Zhao; Chongbo Yang; Fei Jing
Journal:  Wien Klin Wochenschr       Date:  2018-05-29       Impact factor: 1.704

7.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

8.  CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Authors:  Baoying Liu; Ashwin Dhanda; Sima Hirani; Emily L Williams; H Nida Sen; Fernando Martinez Estrada; Diamond Ling; Ian Thompson; Megan Casady; Zhiyu Li; Han Si; William Tucker; Lai Wei; Shayma Jawad; Amol Sura; Jennifer Dailey; Susan Hannes; Ping Chen; Jason L Chien; Siamon Gordon; Richard W J Lee; Robert B Nussenblatt
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

9.  Expression of FcgammaRs and mCD14 on polymorphonuclear neutrophils and monocytes may determine periodontal infection.

Authors:  E A Nicu; U van der Velden; V Everts; B G Loos
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

10.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.